Found 10 matching trials
24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003 and Placebo MDI PHASE3 Randomized, Phase IIIb, Two-period, Two-treatment Double-blind, Multi-cente...
Show More Location
Multiple Locations
Learn More & Join Trial
Pharmacokinetics and Safety Study of PT010 and PT003 in Healthy Chinese Adult Subjects PHASE1 A study to assess the pharmacokinetics and safety of two doses of PT010 and...
Show More Learn More & Join Trial
A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD PHASE3 Study to Evaluate the Effects of PT003 and Placebo MDI on Specific Image Ba...
Show More Learn More & Join Trial
Phase I Study Evaluating the Safety and Pharmacokinetics of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI) in Healthy Volunteers PHASE1 This is a Phase I, Randomized, Double-Blind Within Device, Single-Dose, Fou...
Show More Location
Pearl Therapeutics Study Site
Learn More & Join Trial
PK Study of PT003 and PT001 in Japanese Healthy Subjects PHASE1 A Randomized, Double-Blind, Single-Dose, Four-Period, Four-Treatment, Cross...
Show More Learn More & Join Trial
Study to Evaluate the Treatment Effect of PT003 on Cardiovascular Hemodynamics in Subjects With Moderate to Severe COPD PHASE3 This is a randomized, double-blind, placebo-controlled, single-center, chro...
Show More Learn More & Join Trial
Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD PHASE3 This is an open-label, multi-center study to evaluate the accuracy, reliabi...
Show More Location
Pearl Investigative Site
Learn More & Join Trial
Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD PHASE3 This is a Randomized, Phase III, Two-period, Open-label, Chronic-dosing (7 ...
Show More Location
Pearl Investigative Site
Learn More & Join Trial
Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD PHASE3 A chronic dosing (24 weeks) study to assess the efficacy and safety GFF MDI...
Show More Learn More & Join Trial
Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1) PHASE3 The overall objective of this study is to assess the efficacy and safety of...
Show More Location
Pearl Investigative Site
Learn More & Join Trial